The FDA authorized the Novavax COVID-19 vaccine, providing an alternative to mRNA-based vaccines; HHS guidance urged pharmacies to continue to fill prescriptions for pills used for abortion; the House passed a bill expanding health care benefits for veterans who inhaled toxic fumes on duty.
The FDA approved the protein-based Novavax COVID-19 vaccine for adults on July 13, providing an alternative vaccine option to Americans, as the vaccine is different in composition to the Moderna and Pfizer mRNA-based vaccines. The CDC’s Advisory Committee on Immunization Practices plans to meet on July 19 to discuss its recommendation on use of the vaccine, which is a 2-shot series given 21 days apart. The vaccine had already been approved in 40 different countries and the European Union, although manufacturing issues had hindered its US approval. The Biden administration announced that it had secured 3.2 million doses of the vaccine, which will be shipped to states pending the CDC committee recommendation.
Guidance issued by HHS urges pharmacies to continue filling prescriptions for abortion medication after reports of pharmacists turning women away. The federal officials have pointed to federal civil rights laws and provisions in the Affordable Care Act that say that pharmacists cannot make their own decisions on the suitability of the medication. Health care providers who do not comply could risk losing federal funding and incurring financial penalties. The warning comes as women nationwide are facing restrictions on medications that could be used to cause miscarriages and end ectopic pregnancies, among other medical uses.
The House passed a revised version of a bill that would expand benefits for veterans. The bill, which was passed in a 342-88 vote, would expand health care and disability benefits to more than 3.5 million veterans who were exposed to toxic substances in the line of duty. The core of the bill would allow veterans who contracted 23 different conditions, including brain cancer and hypertension, while deployed in Iraq, Afghanistan, and other countries to receive health care and disability benefits. This is a change to the current law, which requires veterans to prove that an illness was a direct result of their deployment.
Evolving Roles of Antibody-Drug Conjugates in the Treatment of NSCLC
September 7th 2025Antibody-drug conjugates are rapidly reshaping the treatment landscape of non–small cell lung cancer (NSCLC), with advances in design, clinical efficacy, and regulatory approvals tempered by ongoing challenges in toxicity, resistance, and biomarker optimization.
Read More
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Comparing Global Standards in Lung Cancer: NCCN, ESMO, and CHEST Guidelines
September 6th 2025National Comprehensive Cancer Network (NCCN), the European Society for Medical Oncology (ESMO), and the American College of Chest Physicians (CHEST) offer complementary yet distinct frameworks for lung cancer care, reflecting differences in evidence evaluation, regional adaptation, and policy integration.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Evolving Roles of Antibody-Drug Conjugates in the Treatment of NSCLC
September 7th 2025Antibody-drug conjugates are rapidly reshaping the treatment landscape of non–small cell lung cancer (NSCLC), with advances in design, clinical efficacy, and regulatory approvals tempered by ongoing challenges in toxicity, resistance, and biomarker optimization.
Read More
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Comparing Global Standards in Lung Cancer: NCCN, ESMO, and CHEST Guidelines
September 6th 2025National Comprehensive Cancer Network (NCCN), the European Society for Medical Oncology (ESMO), and the American College of Chest Physicians (CHEST) offer complementary yet distinct frameworks for lung cancer care, reflecting differences in evidence evaluation, regional adaptation, and policy integration.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
2 Commerce Drive
Cranbury, NJ 08512